Evidence map›Paper›PMID 24271033›Full record

ArticlePsychopharmacology2014

Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration.

A Aristieta, T Morera-Herreras, J A Ruiz-Ortega, C Miguelez, I Vidaurrazaga, A Arrue, M Zumarraga, L Ugedo

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Preferential Modulatory Action of 5-HTThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  3. Article
  4. The effect of 5-HTBritish journal of pharmacology · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

A AristietaDepartment of Pharmacology, Faculty of Medicine and Dentistry, University of the Basque Country UPV/EHU, 48940, Leioa, Spain.
T Morera-Herreras
J A Ruiz-Ortega
C Miguelez
I Vidaurrazaga
A Arrue
M Zumarraga
L Ugedo
University of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleWithin the basal ganglia, the subthalamic nucleus (STN) is the only glutamatergic structure and occupies a central position in the indirect pathway. In rat, the STN receives serotonergic input from the dorsal raphe nucleus and expresses serotonergic receptors.

objectiveThis study examined the consequences of serotonergic neurotransmission modulation on STN neuron activity.

methodsIn vivo single-unit extracellular recordings, HPLC determination, and rotarod and bar test were performed in control, 4-chloro-DL-phenylalanine methyl ester hydrochloride- (pCPA, a serotonin synthesis inhibitor) and chronically fluoxetine-treated rats.

resultsThe pCPA treatment and the administration of serotonin (5-HT) receptor antagonists increased number of bursting neurons in the STN. The systemic administration of the 5-HT(1A) agonist, 8-OH-DPAT, decreased the firing rate and increased the coefficient of variation of STN neurons in pCPA-treated rats but not in control animals. Additionally, microinjection of 8-OH-DPAT into the STN reduced the firing rate of STN neurons, while microinjection of the 5-HT(2C) agonist, Ro 60-0175, increased the firing rate in both control and fluoxetine-treated animals. Finally, the fluoxetine challenge increased the firing rate of STN neurons in fluoxetine-treated rats and induced catalepsy.

conclusionsOur results indicate that the depletion and the blockage of 5-HT modify STN neuron firing pattern. STN neuron activity is under the control of 5-HT(1A) and 5-HT(2C) receptors located both inside and outside the STN. Finally, fluoxetine increases STN neuron activity in chronically fluoxetine-treated rats, which may explain the role of this nucleus in fluoxetine-induced extrapyramidal side effects.

Indexed as

8-Hydroxy-2-(di-n-propylamino)tetralinAction PotentialsAnimalsEthylaminesFenclonineFluoxetineIndolesMaleMotor ActivityNeuronsRats, Sprague-DawleyReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2CSelective Serotonin Reuptake InhibitorsSerotonin 5-HT1 Receptor AgonistsSerotonin 5-HT2 Receptor Agonists4-chlorophenylalanine methyl ester8-Hydroxy-2-(di-n-propylamino)tetralinEthylaminesFenclonineFluoxetineIndolesReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2CRo 60-0175Selective Serotonin Reuptake InhibitorsSerotonin 5-HT1 Receptor AgonistsSerotonin 5-HT2 Receptor AgonistsSerotonin AgentsSerotonin Antagonists

Identifiers

PMID24271033
PMCPMC3984421
OpenAlexW2100052979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.